Jump Financial, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$83.14 - $145.99 $2.94 Million - $5.17 Million	35,400 New	35,400 $5.16 Million
Q1 2022 May 12, 2022	SELL	$110.08 - $142.92 $1.04 Million - $1.35 Million	-9,475 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$99.73 - $148.48 $702,398 - $1.05 Million	7,043 Added 289.6%	9,475 $1.31 Million
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $240,403 - $337,829	2,432 New	2,432 $337,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.